Bath & Body Works
BBWI
$16.72
-6.64%
Bath & Body Works, Inc. is a specialty retailer of home fragrance and fragrant body care products, operating through its Bath & Body Works, White Barn, and C.O. Bigelow brands across a network of more than 1,900 primarily North American stores, supplemented by digital and a small but growing international footprint. The company is the dominant U.S. mall-based purveyor of candles, hand soaps, sanitizers, and body care, holding a category-leading position in home fragrance that few competitors can match at scale, though it remains a discretionary, mall-traffic-dependent retailer rather than a platform or technology-driven business. The current investor narrative centers on a nascent turnaround: the Q2 fiscal 2026 earnings beat and raised full-year outlook, reported in late August 2026, sent shares up 7.5% in a single session on the back of a return to direct sales growth, and management is leaning on store upgrades, digital expansion, international growth, and adjacent categories such as lip care to offset a still-challenged core. That optimism is heavily contested, however, as revenue was still down 3.2% year over year in the most recent quarter, the stock has lost roughly a third of its value over the past year, and sell-side sentiment has soured, with Goldman Sachs downgrading to Sell in July 2026, leaving investors to debate whether this is a genuine inflection or a value trap in a structurally pressured mall retail category.…
BBWI
Bath & Body Works
$16.72
Related headlines
Investment Opinion: Should I buy BBWI Today?
The synthesized recommendation is a Hold with a slight bullish tilt for risk-tolerant investors. The core thesis is that BBWI is a deeply undervalued, cash-generative retailer with a dominant market position and a nascent turnaround that could unlock significant value, but the persistent revenue decline and structural headwinds warrant caution. The analyst consensus rating is Hold with an average target price of $24.06, implying 29.6% upside, but the wide range ($17 to $54) reflects high uncertainty.\n\nSupporting evidence includes the forward PE of 6.66x, which is well below the market average and the stock's own historical multiple; the 43.7% gross margin and 15.4% operating margin, which demonstrate pricing power; the $909 million in trailing free cash flow, which supports a 3.62% dividend yield; and the recent Q2 earnings beat that led to raised guidance. However, revenue growth remains negative at -3.2% year over year, and the company has a negative equity position, which limits financial flexibility.\n\nThe biggest risks that could invalidate the thesis are a continued decline in mall traffic, a failure to sustain the Q2 sales momentum, and a deterioration in the balance sheet. The rating would upgrade to Buy if revenue growth turns positive for two consecutive quarters and operating margins stabilize above 15%, or if the stock drops below $15 with no change in fundamentals. It would downgrade to Sell if revenue declines accelerate below -5% or if free cash flow falls below $700 million. Relative to its history and peers, BBWI appears undervalued on a cash flow basis, but the discount may be justified by structural challenges.
Sign up to view all
BBWI 12-Month Price Forecast
BBWI presents a classic value vs. growth trap dilemma. The stock is statistically cheap on every metric, with a forward PE of 6.66x and a free cash flow yield of nearly 24%, yet the market is pricing in continued decline due to structural headwinds in mall retail. The recent Q2 earnings beat and raised guidance provide a glimmer of hope, but the revenue decline of 3.2% YoY shows the core business is still shrinking. The high short interest (short ratio 2.66) and beta of 1.37 suggest significant volatility and potential for a short squeeze if positive news continues. I would upgrade to bullish if revenue growth turns positive and margins expand, and downgrade to bearish if revenue declines accelerate or free cash flow deteriorates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bath & Body Works's 12-month outlook, with a consensus price target around $24.06 and implied upside of +43.9% versus the current price.
Average Target
$24.06
0 analysts
Implied Upside
+43.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$17 - $54
Analyst target range
Bulls vs Bears: BBWI Investment Factors
The bear case currently has stronger evidence, primarily due to the persistent revenue decline, negative equity, and significant underperformance relative to the market. However, the bull case is supported by deep value multiples, strong free cash flow, and a recent earnings beat that suggests a potential inflection. The most important tension is whether the Q2 return to direct sales growth can be sustained and translate into positive total revenue growth, or whether it is merely a temporary blip in a structurally declining mall retail category. If revenue growth turns positive in the coming quarters, the stock could re-rate sharply; if the decline continues, the value trap thesis will likely prevail.
Bullish
- Deep Value Multiples: BBWI trades at a trailing PE of 7.1x and a forward PE of 6.66x, roughly half the broader market multiple. The price-to-sales ratio of 0.63x and EV/EBITDA of 6.1x suggest the market is pricing in a no-growth or declining scenario, leaving room for multiple expansion if the turnaround gains traction.
- Strong Free Cash Flow: The company generated $909 million in trailing twelve-month free cash flow, which equates to a price-to-free-cash-flow ratio of just 4.19x. This cash generation supports the 3.62% dividend yield and provides ample liquidity to fund store upgrades and digital initiatives without straining the balance sheet.
- Q2 Earnings Beat and Raised Guidance: In late August 2026, BBWI reported Q2 fiscal 2026 earnings that beat expectations and management raised the full-year outlook, sending shares up 7.5% in a single session. The return to direct sales growth, even as total revenue declined 3.2% year over year, signals that the core business may be stabilizing.
- Analyst Target Implies Significant Upside: The average analyst price target of $24.06 represents a 29.6% upside from the current price of $18.57. Even the low target of $17.00 is only 8.5% below the current price, suggesting limited downside according to sell-side estimates, while the high target of $54.00 implies a 190% return.
Bearish
- Persistent Revenue Decline: Revenue fell 3.2% year over year in the most recent quarter to $1.378 billion, marking continued top-line pressure. The decline is driven by weak mall traffic and a consumer shift away from discretionary spending, and there is no clear evidence that this trend has reversed.
- Negative Shareholder Equity: The company has a negative debt-to-equity ratio of -3.87 and a negative price-to-book ratio of -3.61, indicating that liabilities exceed assets. This is a result of aggressive share buybacks and debt-funded capital returns, which have eroded the equity base and increased financial risk.
- Underperformance and High Volatility: BBWI has lost 33.4% over the past year, vastly underperforming the S&P 500's 16.2% gain, resulting in a relative strength of -49.6%. The stock's beta of 1.37 and max drawdown of -53.4% highlight its high volatility and sensitivity to market swings.
- Analyst Downgrade and Hold Consensus: Goldman Sachs downgraded BBWI to Sell in July 2026, and the overall analyst consensus is 'Hold' with a recommendation mean of 2.58. This suggests that many analysts are not convinced the turnaround will succeed, and the low target of $17.00 is below the current price.
BBWI Technical Analysis
Beta
1.37
1.37x market volatility
Max Drawdown
-53.4%
Largest decline past year
52-Week Range
$14-$27
Price range past year
Annual Return
-36.8%
Cumulative gain past year
| Period | BBWI Return | S&P 500 |
|---|---|---|
| 1m | -13.9% | -2.4% |
| 3m | -18.4% | +2.2% |
| 6m | -17.8% | +14.8% |
| 1y | -36.8% | +14.6% |
| ytd | -19.4% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BBWI Fundamental Analysis
Quarterly Revenue
$1.4B
2026-05
Revenue YoY Growth
-3.2%
YoY Comparison
Gross Margin
42.6%
Latest Quarter
Free Cash Flow
$909000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BBWI Overvalued?
PE
7.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company carries a negative debt-to-equity ratio of -3.87 and negative book value, reflecting years of debt-funded buybacks that have left little equity cushion. While free cash flow of $909 million is robust, interest expense of $69 million per quarter consumes a meaningful portion of operating income, and any downturn in cash generation could strain the ability to service debt and maintain the dividend. Additionally, revenue concentration in North America (96% of sales) and reliance on mall traffic (77% of sales) make the company vulnerable to regional economic weakness and changing consumer behavior.\n\nMarket and competitive risks are also elevated. The stock's beta of 1.37 indicates it is more volatile than the broader market, and its 1-year relative strength of -49.6% shows severe underperformance. The specialty retail sector faces intense competition from online players, mass merchants, and direct-to-consumer brands, which could erode BBWI's market share. Furthermore, the Goldman Sachs downgrade to Sell in July 2026 highlights concerns about the sustainability of the turnaround, and any further analyst downgrades could pressure the stock. Macro sensitivity is high, as discretionary spending on home fragrance and body care is among the first to be cut during economic downturns.\n\nThe worst-case scenario would involve a continued decline in mall traffic, a failed turnaround, and a recession that hits discretionary spending. In this scenario, revenue could decline further, margins could compress, and the stock could retest its 52-week low of $14.28, representing a 23% downside from the current price of $18.57. If the company's financial condition deteriorates, the dividend could be cut, triggering a sell-off that drives the stock below the analyst low target of $17.00 and potentially towards the historical max drawdown of -53.4%, implying a price as low as $8.65. Investors could lose 23% to 53% of their capital in such an adverse scenario.
FAQ
The most severe risk is the persistent revenue decline, which was -3.2% year over year in the latest quarter, and could accelerate if mall traffic weakens further. Financial risk is also high due to negative equity and a debt-to-equity ratio of -3.87, which limits financial flexibility and could lead to a dividend cut. Competitive risks include intense pressure from online retailers and mass merchants, which could erode BBWI's market share in home fragrance. Macroeconomic sensitivity is another concern, as discretionary spending on candles and body care is vulnerable during recessions, and the stock's beta of 1.37 means it is more volatile than the market. Finally, analyst sentiment is weak, with a Hold consensus and a recent downgrade to Sell by Goldman Sachs, which could trigger further selling if negative news continues.
Our 12-month forecast has three scenarios: a base case (50% probability) with a target range of $22-$26, assuming modest improvement and stable margins; a bull case (25% probability) with a target of $27-$32, driven by a successful turnaround and revenue growth; and a bear case (25% probability) with a target of $14-$17, if the decline accelerates. The most likely scenario is the base case, which aligns with the analyst average target of $24.06. The key assumption is that revenue declines slow to 1-2% and free cash flow remains above $800 million. However, given the high uncertainty, investors should be prepared for volatility.
BBWI appears undervalued on most metrics. Its trailing PE of 7.1x and forward PE of 6.66x are well below the broader market and its own historical average. The price-to-sales ratio of 0.63x and EV/EBITDA of 6.1x are also low, suggesting the market is pricing in little to no growth. However, the negative price-to-book ratio of -3.61 reflects the company's negative equity, which is a red flag. Compared to peers in specialty retail, BBWI trades at a discount, but that discount may be justified by its declining revenue and mall-based model. The market seems to expect continued challenges, so any positive surprise could lead to multiple expansion.
BBWI could be a good buy for value-oriented investors with a high risk tolerance, given its forward PE of 6.66x and 29.6% upside to the average analyst target of $24.06. The company generates $909 million in free cash flow and pays a 3.62% dividend yield, which provides some downside protection. However, the stock has lost 33.4% over the past year and revenue is still declining, so it is not a low-risk investment. The recent Q2 earnings beat and raised guidance are encouraging, but the turnaround is unproven. Investors should consider it a speculative value play rather than a core holding.
BBWI is more suitable for long-term value investors than short-term traders. The stock's high beta of 1.37 and max drawdown of -53.4% indicate significant volatility, making it risky for short-term trading. The dividend yield of 3.62% and strong free cash flow support a buy-and-hold strategy, but the turnaround may take several quarters to materialize. A minimum holding period of 2-3 years is advisable to allow the company's initiatives to bear fruit. Short-term traders might find opportunities around earnings announcements, but the overall trend has been negative, so timing is crucial. Investors should monitor quarterly results closely and be prepared to adjust their thesis if fundamentals deteriorate.